Literature DB >> 14993396

The emergence of behavioral pharmacology.

James E Barrett1.   

Abstract

Beginning over five decades ago, a pioneering series of studies was conducted that had a profound impact on the field of pharmacology. The impact of those studies was so forceful and sweeping that the discipline of pharmacology was modified in scope and practice by the emergence of a new discipline-behavioral pharmacology. The studies initiating this cascade of events stemmed from the Psychobiology Laboratory at Harvard Medical School and were associated with research conducted by Peter B. Dews, Roger T. Kelleher, and William H. Morse. These individuals shaped the conceptual framework, the experimental direction, as well as the principal focus, that defined and dominated the field of behavioral pharmacology for decades following their initial work in the 1950s. This article will highlight some of the main themes and implications of the work initiated by Dews, Kelleher, and Morse. In particular, I will focus on: i) schedule-controlled behavior and response rate; ii) schedules using noxious stimuli; and iii) the use of second-order schedules.

Mesh:

Substances:

Year:  2002        PMID: 14993396     DOI: 10.1124/mi.2.8.470

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  9 in total

1.  Behavior analysis and the growth of behavioral pharmacology.

Authors:  Victor G Laties
Journal:  Behav Anal       Date:  2003

2.  Effects of cocaine on performance under fixed-interval schedules with a small tandem ratio requirement.

Authors:  Jonathan W Pinkston; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2004-11       Impact factor: 2.468

3.  Behavioral determinants of drug action. The contributions of Peter B. Dews.

Authors:  James E Barrett
Journal:  J Exp Anal Behav       Date:  2006-11       Impact factor: 2.468

4.  Pioneer in behavioral pharmacology: a tribute to Joseph V. Brady.

Authors:  James E Barrett
Journal:  J Exp Anal Behav       Date:  2008-11       Impact factor: 2.468

5.  Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.

Authors:  Ming Li; Tao Sun; Alexa Mead
Journal:  J Neural Transm (Vienna)       Date:  2011-10-11       Impact factor: 3.575

6.  Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.

Authors:  Min Feng; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

7.  Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

Authors:  Chen Zhang; Yiru Fang; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2010-12-29       Impact factor: 3.533

8.  Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.

Authors:  Ming Li; Wei He; Alexa Mead
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

9.  Use of operant performance to guide and evaluate medical treatment in an adult male cynomolgus macaque (Macaca fascicularis).

Authors:  Lindsey R Hamilton; David M Cox; Todd M Myers
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-11       Impact factor: 1.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.